A therapeutic aerosol benefits the patient only if the medication deposits in the airway. Advances in nebulizer design have made them more efficient and "user friendly," but the greatest problem with administering aerosolized medication continues to be educating patients and caregivers to use aerosol devices properly and consistently. Misuse and nonuse are the greatest impediments to effective aerosol delivery. The respiratory pattern and degree of patient cooperation also pro-foundly affect aerosol deposition, and those effects are greatly magnified in small children. There are many misconceptions about nebulizer use and nebulizer equipment, even in teaching hospitals, and these can have serious consequences when patients do not receive the medication they need. This review discusses how airway physiology, nebulizer technology, and patient education relate to appropriate nebulizer use. Education is critically important, but unfortunately it is often a misun-derstood or neglected part of aerosol administration.
FinkJB, DhandR.Aerosol therapy. In: FinkJB, HuntG, editors. Clinical practice in respiratory care. Philadelphia: Lippincott Raven; 1998.
3.
HessD, FisherD, WilliamsP, PoolerS, KacmarekRM. Medication nebulizer performance: effects of diluent volume, nebulizer flow, and nebulizer brand. Chest1996;110(2):498–505.
4.
AlvineGF, RodgersP, FitzsimmonsKM, AhrensRC. Disposable jet nebulizers: how reliable are they?Chest1992;101(2):316–319.
5.
HadfieldJW, WindebankWJ, BatemanJRM. Is driving gas flow rate clinically important for nebulizer therapy?Br J Dis Chest1986;80(1):50–54.
6.
Nebulizer therapy. Guidelines. British Thoracic Society Nebulizer Project Group. Thorax1997;52Suppl 2:S4–24.
7.
HessD, HorneyD, SnyderT.Medication-delivery performance of eight small-volume, hand-held nebulizers: effects of diluent volume, gas flowrate and nebulizer model. Respir Care1989;34(8):717–723.
8.
EverardML, ClarkAR, MilnerAD. Drug delivery from jet nebulisers. Arch Dis Child1992;67(5):586–591.
9.
ReisnerC, KatialRK, BartelsonBB, BuchmeirA, RosenwasserLJ, NelsonHS. Characterization of aerosol output from various nebulizer/compressor combinations. Ann Allergy Asthma Immunol2001;86(5):566–574.
RubinBK, FinkJB. Aerosol therapy for children. Respir Care Clin N Am2001;7(2):175–213.
12.
OnhojJ [Anhøj J], ThorssonL, BisgaardH.Lung deposition of inhaled drugs increases with age. Am J Respir Crit Care Med2000;162(5):1819–1822.
13.
MarguetC, CoudercL, Le RouxP, JeannotE, LefayV, MalletE.Inhalation treatment: errors in application and difficulties in acceptance of the devices are frequent in wheezy infants and young children. Pediatr Allergy Immunol2001;12(4):224–230.
14.
LowenthalD, KattanM.Facemasks versus mouthpieces for aerosol treatment of asthmatic children. Pediatr Pulmonol1992;14(3):192–196.
15.
AmiravI, NewhouseMT. Aerosol therapy with valved holding chambers in young children: importance of the facemask seal. Pediatrics2001;108(2):389–394.
16.
MurakamiG, IgarashiT, AdachiY, MatsunoM, AdachiY, SawaiM, et al. Measurement of bronchial hyperreactivity in infants and preschool children using a new method. Ann Allergy1990;64(4):383–387.
17.
IlesR, ListerP, EdmundsAT. Crying significantly reduces absorption of aerosolised drug in infants. Arch Dis Child1999;81(2):163–165.
18.
JanssensH.Aerosol therapy in young children. Doctoral Thesis. Erasmus University, Rotterdam, The Netherlands. 2001:138.
19.
TablanOC, AndersonLJ, ArdenNH, BreimanRF, ButlerJC, McNeilMM. Guideline for prevention of nosocomial pneumonia. The Hospital Infection Control Practices Advisory Committee, Centers for Disease Control and Prevention. Am J Infect Control1994;22(4):247–292. Erratum in: Am J Infect Control 1994;22(6):351 and Am J Infect Control 1994;22(5):324.
20.
CravenDE, LichtenbergDA, GoularteTA, MakeBJ, McCabeWR. Contaminated medication nebulizers in mechanical ventilator circuits: source of bacterial aerosols. Am J Med1984;77(5):834–838.
21.
HamillRJ, HoustonED, GeorghiuPR, WrightCE, KozaMA, CadleRM, et al. An outbreak of Burkholderia (formerly Pseudomonas) cepacia respiratory tract colonization and infection associated with nebulized albuterol therapy. Ann Intern Med1995;122(10):762–766.
22.
OieS, KamiyaA.Bacterial contamination of aerosol solutions containing antibiotics. Microbios1995;82(331):109–113.
23.
StandaertTA, MorlinGL, Williams-WarrenJ, JoyP, PepeMS, WeberA, RamseyBW. Effects of repetitive use and cleaning techniques of disposable jet nebulizers on aerosol generation. Chest1998;114(2):577–586.
24.
MerkusPJ, van Essen-ZandvlietEE, ParlevlietE, BorsboomG, SterkPJ, KerrebijnKF, QuanjerPH. Changes of nebulizer output over the years. Eur Respir J1992;5(4):488–491.
25.
BosleyCM, CordenZM, ReesPJ, CochraneGM. Psychological factors associated with use of home nebulized therapy for COPD. Eur Respir J1996;9(11):2346–2450.
26.
YukselB, GreenoughA.Comparison of the effects on lung function of two methods of bronchodilator administration. Respir Med1994;88(3):229–233.
27.
van der PalenJ, KleinJJ, KerkhoffAH, van HerwaardenCL, SeydelER. Evaluation of the long-term effectiveness of three instruction modes for inhaling medicines. Patient Educ Couns1997;32(1 Suppl):S87–S95.
